開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
美國國家公路交通安全管理局對特斯拉(TSLA.O)Cybercab自我認證展開調查。
2026-09-04
美國國家公路交通安全管理局對特斯拉(TSLA.O)Cybercab自我認證展開調查。
返回
其他消息
2026-09-04
KATAYAMA, Japan's finance minister, said she had taken note of Prime Minister Sanae Takaichi's remarks that new government bond issuance could be close to ¥40 trillion.
KATAYAMA, Japan's finance minister, said she had taken note of Prime Minister Sanae Takaichi's remarks that new government bond issuance could be close to ¥40 trillion.
2026-09-04
The National Healthcare Security Administration said it will continue expanding centralized procurement coverage and regularly carry out nationally organized centralized procurement for drugs and medical consumables, while guiding provinces to advance interprovincial alliance purchasing. It will stick to the rule that new drugs are excluded from centralized procurement and non-new drugs are included, and will target high-clinical-use, inflated-price products—including traditional Chinese medicin
The National Healthcare Security Administration said it will continue expanding centralized procurement coverage and regularly carry out nationally organized centralized procurement for drugs and medical consumables, while guiding provinces to advance interprovincial alliance purchasing. It will stick to the rule that new drugs are excluded from centralized procurement and non-new drugs are included, and will target high-clinical-use, inflated-price products—including traditional Chinese medicine, biologics and medical consumables—to lower patient costs. The agency said it will optimize procurement rules under the principles of steady clinical supply, quality assurance, anti-internal competition and preventing bid collusion, emphasizing clinical demand and implementing a ‘‘remove abnormally high prices; do not award volume to abnormally low prices’’ policy to steer fair competition and crack down on collusion. It will coordinate with the drug regulator to tighten quality thresholds, carry out full-coverage inspections of nationally selected suppliers and product sampling, and impose strict sanctions on firms found in breach.
Chat with us
, powered by
LiveChat